MedPath

Palliative Radiation for Advanced Cervical Cancer

Phase 3
Conditions
Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified
Registration Number
CTRI/2019/06/019929
Lead Sponsor
Tata memorial Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Locally advanced cervical cancer (Stage III B-IV A) deemed unsuitable for full course radical pelvic radiotherapy or chemoradiation due to the following reasons:

- Very large volume hard fixed disease infiltrating pelvic wall muscles and ligaments on clinical examination also classified

clinically as â??frozen pelvisâ?? wherein curative intent treatment is not envisaged or feasible.

- Fistulous communication between tumour growth and rectum and bladder >2x2 cm in size (as judged by cystoscopy for bladder infiltration or clinical or proctosigmoidoscopy examination

for rectal/sigmoid infiltration) wherein radical intent treatment is not intended or feasible and patient is not a candidate for pelvic exentration.

- Deranged renal parameters as measured by Serum Creatinine >3 mg/dl wherein diversion nephrostomy is not planned by the multidisciplinary team due to anticipated poor

clinical outcomes.Furthermore concurrence for palliative intent radiotherapy should

be corroborated by 2 staff radiation oncologists.

2. Moderate to Severe Pain on Numerical Rating Score (Score 4 or higher).

3. Anticipated survival < 12 months.

4. Patients with stage IVB with local disease extent as described in section 1 but systemic chemotherapy is not possible either due

to deranged renal function or anticipated poor tolerance.

Exclusion Criteria

1. Patients with distant metastasis needing upfront systemic therapy.

2. Presence of retroviral disease

3. Non-compliant for follow up.

4. Expected survival <3 months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath